Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca2+ sensitivity
Open Access
- 27 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 99 (1) , 65-73
Abstract
The pure form of familial dilated cardiomyopathy (DCM) is mainly caused by mutations in genes encoding sarcomeric proteins. Previous measurements using recombinant proteins suggested that DCM mutations in thin filament proteins decreased myofibrillar Ca2+ sensitivity, but exceptions were reported. We re-investigated the molecular mechanism of familial DCM using native proteins. We used the quantitative in vitro motility assay and native troponin and tropomyosin to study DCM mutations in troponin I, troponin T, and α-tropomyosin. Four mutations reduced myofilament Ca2+ sensitivity, but one mutation (TPM1 E54K) did not alter Ca2+ sensitivity and another (TPM1 D230N) increased Ca2+ sensitivity. In thin filaments from normal human and mouse heart, protein kinase A (PKA) phosphorylation of troponin I caused a two- to three-fold decrease in myofibrillar Ca2+ sensitivity. However, Ca2+ sensitivity did not change with the level of troponin I phosphorylation in any of the DCM-mutant containing thin filaments (E40K, E54K, and D230N in α-tropomyosin; R141W and ΔK210 in cardiac troponin T; K36Q in cardiac troponin I; G159D in cardiac troponin C, and E361G in cardiac α-actin). This ‘uncoupling’ was observed with native mutant protein from human and mouse heart and with recombinant mutant protein expressed in baculovirus/Sf9 systems. Uncoupling was independent of the fraction of mutated protein present above 0.55. We conclude that DCM-causing mutations in thin filament proteins abolish the relationship between myofilament Ca2+ sensitivity and troponin I phosphorylation by PKA. We propose that this blunts the response to β-adrenergic stimulation and could be the cause of DCM in the long term.Keywords
This publication has 45 references indexed in Scilit:
- Truncations of Titin Causing Dilated CardiomyopathyNew England Journal of Medicine, 2012
- Functional Characterization of TNNC1 Rare Variants Identified in Dilated CardiomyopathyJournal of Biological Chemistry, 2011
- Molecular Mechanism of the E99K Mutation in Cardiac Actin (ACTC Gene) That Causes Apical Hypertrophy in Man and MouseJournal of Biological Chemistry, 2011
- Human actin mutations associated with hypertrophic and dilated cardiomyopathies demonstrate distinct thin filament regulatory properties in vitroJournal of Molecular and Cellular Cardiology, 2010
- Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin MutationJACC, 2010
- Stress-induced dilated cardiomyopathy in a knock-in mouse model mimicking human titin-based diseaseJournal of Molecular and Cellular Cardiology, 2009
- Functional aberration of myofibrils by cardiomyopathy-causing mutations in the coiled-coil region of the troponin-core domainBiochemical and Biophysical Research Communications, 2009
- The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathyEuropean Journal of Human Genetics, 2009
- The changes of the cardiac structure and function in cTnTR141W transgenic miceInternational Journal of Cardiology, 2008
- The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxationBiochemical and Biophysical Research Communications, 2008